Adverum Cash And Short Term Investments from 2010 to 2024
| ADVM Stock | USD 9.30 0.31 3.23% |
Cash And Short Term Investments | First Reported 2013-12-31 | Previous Quarter 96.5 M | Current Value 193.3 M | Quarterly Volatility 93.8 M |
Check Adverum Biotechnologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Adverum main balance sheet or income statement drivers, such as Depreciation And Amortization of 5.9 M, Selling General Administrative of 31.8 M or Total Revenue of 2.8 M, as well as many exotic indicators such as Price To Sales Ratio of 23.04, Dividend Yield of 0.0 or PTB Ratio of 0.96. Adverum financial statements analysis is a perfect complement when working with Adverum Biotechnologies Valuation or Volatility modules.
Adverum | Cash And Short Term Investments |
Latest Adverum Biotechnologies' Cash And Short Term Investments Growth Pattern
Below is the plot of the Cash And Short Term Investments of Adverum Biotechnologies over the last few years. Short Term Investments is an account in the current assets section of Adverum Biotechnologies balance sheet. This account contains Adverum Biotechnologies investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Adverum Biotechnologies fairly quickly. It is the sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash. Adverum Biotechnologies' Cash And Short Term Investments historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Adverum Biotechnologies' overall financial position and show how it may be relating to other accounts over time.
| Cash And Short Term Investments | 10 Years Trend |
|
Cash And Short Term Investments |
| Timeline |
Adverum Cash And Short Term Investments Regression Statistics
| Arithmetic Mean | 154,174,647 | |
| Geometric Mean | 36,966,985 | |
| Coefficient Of Variation | 81.54 | |
| Mean Deviation | 98,024,957 | |
| Median | 166,035,000 | |
| Standard Deviation | 125,706,753 | |
| Sample Variance | 15802.2T | |
| Range | 429.4M | |
| R-Value | 0.50 | |
| Mean Square Error | 12690.3T | |
| R-Squared | 0.25 | |
| Significance | 0.06 | |
| Slope | 14,174,510 | |
| Total Sum of Squares | 221230.6T |
Adverum Cash And Short Term Investments History
About Adverum Biotechnologies Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Adverum Biotechnologies income statement, its balance sheet, and the statement of cash flows. Adverum Biotechnologies investors use historical funamental indicators, such as Adverum Biotechnologies's Cash And Short Term Investments, to determine how well the company is positioned to perform in the future. Although Adverum Biotechnologies investors may use each financial statement separately, they are all related. The changes in Adverum Biotechnologies's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Adverum Biotechnologies's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Adverum Biotechnologies Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Adverum Biotechnologies. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Cash And Short Term Investments | 96.5 M | 91.7 M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Adverum Biotechnologies in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Adverum Biotechnologies' short interest history, or implied volatility extrapolated from Adverum Biotechnologies options trading.
Pair Trading with Adverum Biotechnologies
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Adverum Biotechnologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adverum Biotechnologies will appreciate offsetting losses from the drop in the long position's value.Moving together with Adverum Stock
| 0.77 | VRAX | Virax Biolabs Group Fiscal Year End 12th of June 2024 | PairCorr |
Moving against Adverum Stock
| 0.89 | ACRV | Acrivon Therapeutics Financial Report 14th of May 2024 | PairCorr |
| 0.82 | RVMD | Revolution Medicines Financial Report 13th of May 2024 | PairCorr |
| 0.63 | INDP | Indaptus Therapeutics | PairCorr |
| 0.6 | ELYM | Eliem Therapeutics | PairCorr |
| 0.6 | FBRX | Forte Biosciences Financial Report 20th of May 2024 | PairCorr |
The ability to find closely correlated positions to Adverum Biotechnologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Adverum Biotechnologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Adverum Biotechnologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Adverum Biotechnologies to buy it.
The correlation of Adverum Biotechnologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Adverum Biotechnologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Adverum Biotechnologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Adverum Biotechnologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Adverum Biotechnologies Correlation against competitors. To learn how to invest in Adverum Stock, please use our How to Invest in Adverum Biotechnologies guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Complementary Tools for Adverum Stock analysis
When running Adverum Biotechnologies' price analysis, check to measure Adverum Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adverum Biotechnologies is operating at the current time. Most of Adverum Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Adverum Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adverum Biotechnologies' price. Additionally, you may evaluate how the addition of Adverum Biotechnologies to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Stocks Directory Find actively traded stocks across global markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |
Is Adverum Biotechnologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adverum Biotechnologies. If investors know Adverum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adverum Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (11.60) | Revenue Per Share 0.357 | Quarterly Revenue Growth (0.70) | Return On Assets (0.32) | Return On Equity (0.88) |
The market value of Adverum Biotechnologies is measured differently than its book value, which is the value of Adverum that is recorded on the company's balance sheet. Investors also form their own opinion of Adverum Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Adverum Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adverum Biotechnologies' market value can be influenced by many factors that don't directly affect Adverum Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adverum Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Adverum Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adverum Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.